Ballooned Intercostal Drain Trial
Launched by ROYAL BROMPTON & HAREFIELD NHS FOUNDATION TRUST · Dec 21, 2016
Trial Information
Current as of May 22, 2025
Unknown status
Keywords
ClinConnect Summary
Chest drains are an essential part of the treatment for patients with fluid or air around the lung, which usually causes breathlessness. Draining the fluid or air relieves symptoms and allows investigations to be carried out that can identify a cause for why the fluid or air is there. Chest drains are difficult to secure in place, and sometimes fall out despite the best possible care. This study tests a modified drain that has a small balloon near the end which, when inflated inside the chest cavity, should make it much harder for the drain to fall out of the chest. This was tested in a sma...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age \>16 years
- • 2. Able to give written informed consent
- • 3. Requiring intercostal tube drainage for clinical reasons
- Exclusion Criteria:
- • 1. Inability to provide written informed consent
- • 2. Requiring blunt dissection for intercostal tube insertion
- • 3. Haemothorax
About Royal Brompton & Harefield Nhs Foundation Trust
Royal Brompton & Harefield NHS Foundation Trust is a leading specialist healthcare provider in the United Kingdom, renowned for its expertise in cardiothoracic medicine and respiratory care. Committed to advancing clinical research and improving patient outcomes, the Trust conducts a diverse range of clinical trials aimed at exploring innovative treatments and therapies. With a multidisciplinary team of clinicians and researchers, the Foundation Trust fosters a collaborative environment that prioritizes patient safety and ethical standards, contributing significantly to the global body of medical knowledge and enhancing the quality of care for patients with complex health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Sutton In Ashfield, Nottinghamshire, United Kingdom
Oxford, Oxfordshire, United Kingdom
Patients applied
Trial Officials
Samuel V Kemp, MBBS, MD
Principal Investigator
Royal Brompton and Harefield NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials